Advanced search
Publication Cover
Leukemia & Lymphoma Volume 47, 2006 - Issue 7
Submit an article Journal homepage
91
Views
12
CrossRef citations to date
0
Altmetric
Original

Pegylated interferon plus rituximab in advanced stage, indolent lymphoma: is there CD20 antigen upregulation?

Carol S. Portlock Departments of MedicineCorrespondence[email protected]
,
Owen A. O'Connor Departments of Medicine
,
David J. Straus Departments of Medicine
,
Lisa Rosenzweig Departments of Medicine
,
Otilia Dumitrescu Radiology, Memorial Sloan Kettering Cancer Center, New York, New YorkUSA
,
Oscar Lin Pathology
&
Peter Maslak Departments of Medicine
 show all
Pages 1260-1264 | Received 26 Sep 2005, Accepted 21 Nov 2005, Published online: 01 Jul 2009

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Peter McLaughlin & Stefano Sacchi. (2009) Interferon: Does it still have a role in the 21st century?. Leukemia & Lymphoma 50:10, pages 1562-1563.
Read now
P. Disperati, L. K. Hicks & R. Buckstein. (2007) Rituximab-induced serum sickness in a patient with follicular lymphoma. Leukemia & Lymphoma 48:8, pages 1633-1635.
Read now

Articles from other publishers (10)

Xueqiong Wu, Zhenhui Lv, Wenjia Li, Zhaosheng Meng & Shaw P. Wan. (2020) Epidermolysis bullosa acquisita as an adverse effect from rituximab therapy. Medicine 99:49, pages e23496.
Crossref
Paras Karmacharya, Dilli Ram Poudel, Ranjan Pathak, Anthony A. Donato, Sushil Ghimire, Smith Giri, Madan Raj Aryal & Clifton O. BinghamIIIIII. (2015) Rituximab-induced serum sickness: A systematic review. Seminars in Arthritis and Rheumatism 45:3, pages 334-340.
Crossref
Holbrook E Kohrt, Roch Houot, Aurélien Marabelle, Hearn Jay Cho, Keren Osman, Matthew Goldstein, Ronald Levy & Joshua Brody. (2012) Combination strategies to enhance antitumor ADCC. Immunotherapy 4:5, pages 511-527.
Crossref
G. Le Guenno, M. Ruivard, L. Charra & P. Philippe. (2011) Rituximab-induced serum sickness in refractory immune thrombocytopenic purpura. Internal Medicine Journal 41:2, pages 202-205.
Crossref
Shu-qing Lü, Jian-min Yang, Xian-min Song, Li Chen, Wei-ping Zhang, Xiao-qian Xu, Xiong Ni, Chong-mei Huang, Yi He & Jian-min Wang. (2010) CHOP-like regimen in combination with rituximab and peginterferon alpha-2b in newly-diagnosed diffuse large B-cell Non-Hodgkin’s lymphoma: Experience in a Chinese center. Clinical Oncology and Cancer Research 7:2, pages 103-109.
Crossref
Shoko Goto, Hiroaki Goto, Reo Tanoshima, Hiromi Kato, Hiroyuki Takahashi, Osamu Sekiguchi & Sumio Kai. (2009) Serum sickness with an elevated level of human anti-chimeric antibody following treatment with rituximab in a child with chronic immune thrombocytopenic purpura. International Journal of Hematology 89:3, pages 305-309.
Crossref
Franz Buchegger, Oliver W. Press, Angelika Bischof Delaloye & Nicolas Ketterer. (2008) Radiolabeled and Native Antibodies and the Prospect of Cure of Follicular Lymphoma. The Oncologist 13:6, pages 657-667.
Crossref
Nicholas A. DeMonaco & Samuel A. Jacobs. (2007) Serum Sickness in a Patient With Follicular Lymphoma After Rituximab and Radioimmunotherapy With Ibritumomab Tiuxetan. Clinical Nuclear Medicine 32:12, pages 933-934.
Crossref
. (2007) Current Awareness in Hematological Oncology. Hematological Oncology 25:2, pages 98-105.
Crossref
B Coiffier. (2007) Rituximab therapy in malignant lymphoma. Oncogene 26:25, pages 3603-3613.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.